Imprime PGG improves the efficacy of carboplatin, paclitaxel, and cetuximab chemoimmunotherapy of advanced non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Thomas, Michael [1 ]
Sadjadian, Parvis [2 ]
Kollmeier, Jens [3 ]
Hao, Zhonglin [4 ]
Patchen, Myra [5 ]
Lowe, Jamie [5 ]
Mattson, Paulette [5 ]
Huhn, Richard D. [5 ]
Bose, Nandita [5 ]
Antonysamy, Mary [5 ]
Gargano, Michele [5 ]
Gordon, Keith [5 ]
Schneller, Folker [6 ]
机构：
[1] Univ Clin Heidelberg, Heidelberg, Germany
[2] Johannes Wesling Klinikum Minden, Minden, Germany
[3] Helios Clin Emil von Behring, Berlin, Germany
[4] Georgia Hlth Sci Univ, Augusta, GA USA
[5] Biothera Inc, Eagan, MN USA
[6] Tech Univ Munich, Klinikum Rechts Isar, D-80290 Munich, Germany
来源：
CLINICAL CANCER RESEARCH | 2014年 / 20卷
关键词：
D O I：
10.1158/1078-0432.14AACRIASLC-A26
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A26
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Efficacy of combined radiation, paclitaxel and carboplatin for locally advanced non-small cell lung carcinoma
    Nguyen, NP
    Leonardo, JM
    Karlsson, U
    Vos, P
    Bullock, L
    Thomas, P
    Lepera, P
    Ludin, A
    Chu, C
    Salehpour, M
    Jendrasiak, G
    Sallah, S
    ANTICANCER RESEARCH, 2002, 22 (6B) : 3429 - 3435
  • [32] Weekly paclitaxel (P) in patients with advanced non-small cell lung cancer (NSCLC).
    Nakagawa, K
    Fukuoka, M
    Saijo, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 704S - 704S
  • [33] Cetuximab in advanced non-small-cell lung cancer (NSCLC)
    Pirker, Robert
    LUNG CANCER, 2012, 77 : S13 - S14
  • [34] Carboplatin/nab-Paclitaxel and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): Phase 1 Results
    Gentzler, R. D.
    Mohindra, N. A.
    Hanna, N.
    Chae, Y. K.
    Jalal, S. I.
    Hall, R.
    Villaflor, V. M.
    Reckamp, K. L.
    Koczywas, M.
    Sullivan, D.
    Wood, L.
    Patel, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (01): : 236 - 236
  • [35] Phase II Study of Paclitaxel, Carboplatin, and Cetuximab as First Line Treatment, for Patients with Advanced Non-small Cell Lung Cancer (NSCLC) Results of OPN-017
    Borghaei, Hossein
    Langer, Corey J.
    Millenson, Michael
    Ruth, Karen J.
    Litwin, Samuel
    Tuttle, Holly
    Seldomridge, Judie Sylvester
    Rovito, Marc
    Mintzer, David
    Cohen, Roger
    Treat, Joseph
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (11) : 1286 - 1292
  • [36] Neoadjuvant or adjuvant paclitaxel and carboplatin for stages IB and II non-small cell lung cancer (NSCLC)
    Hainsworth, JD
    Burris, HA
    Greco, FA
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 27 - 27
  • [37] The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias
    Minegishi, Yuji
    Sudoh, Junko
    Kuribayasi, Hideaki
    Mizutani, Hideki
    Seike, Masahiro
    Azuma, Arata
    Yoshimura, Akinobu
    Kudoh, Shoji
    Gemma, Akihiko
    LUNG CANCER, 2011, 71 (01) : 70 - 74
  • [38] Efficacy and safety of adding the retinoid tamibarotene or placebo to paclitaxel/carboplatin for advanced non-small cell lung cancer.
    Arrieta, Oscar
    Levitt, Daniel J.
    Pendergrass, Kelly B.
    Gladkov, Oleg
    Bondarenko, Igor
    Jain, Minish Mahendra
    Wieland, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [39] Chemoradiotherapy in non-small cell lung cancer: Paclitaxel/carboplatin/radiotherapy in regionally advanced disease
    Belani, CP
    Aisner, J
    Bahri, S
    Jett, J
    Day, R
    Capazolli, MJ
    Hiponia, D
    Engstrom, C
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 113 - 116
  • [40] Paclitaxel and carboplatin with simultaneous thoracic irradiation in regionally advanced non-small cell lung cancer
    Belani, CP
    Aisner, J
    Ramanathan, R
    Jett, J
    Greenberger, J
    Day, R
    Capazolli, MJ
    Hiponia, D
    Engstrom, C
    SEMINARS IN RADIATION ONCOLOGY, 1997, 7 (02) : S11 - S14
12345